Evidence map›Paper›PMID 41085816›Full record

ArticleHealth economics review2025

Measurement of catastrophic health expenditures in households with essential hypertension and type 2 diabetes mellitus in cold regions of China.

Haofei Li, Xiangjin Cui, Yiyin Cao, Xu Jin, Jiaxuan Shi, Lei Leng, Lijun Xu, Tiemin Zhai, Weidong Huang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Health economics review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Haofei Li *School of Health Management, Harbin Medical University, Harbin, China.
Xiangjin Cui *School of Health Management, Harbin Medical University, Harbin, China.
Yiyin Cao *School of Health Management, Harbin Medical University, Harbin, China.
Xu JinSchool of Health Management, Harbin Medical University, Harbin, China.
Jiaxuan ShiSchool of Health Management, Harbin Medical University, Harbin, China.
Lei LengSchool of Health Management, Harbin Medical University, Harbin, China.
Lijun XuSchool of Health Management, Harbin Medical University, Harbin, China.
Tiemin ZhaiChina National Health Development Research Center, Beijing, China. ztm@nhei.cn.
Weidong HuangSchool of Health Management, Harbin Medical University, Harbin, China. huangweidong@hrbmu.edu.cn.

Funding

China National Health Development Research Center Project CNHDRC-KJ-W-2023-27National Natural Science Foundation of China 72274045National Natural Science Foundation of China 72374052
6 · The paper itself

Abstract

objectiveThis study examines the incidence, intensity, and inequality of catastrophic health expenditure (CHE) among households with hypertension and type 2 diabetes mellitus (T2DM) in cold regions of China. It also explores key drivers of CHE and compares across diseases.

methodsUsing data from the 2023 Seventh Health Services Survey in Heilongjiang Province, this study applies the World Health Organization's (WHO) normative algorithm for basic food needs to analyze CHE incidence, average gap (G

resultsThe CHE incidence for hypertension and T2DM households were 31.11% and 34.69%, respectively. The G

conclusionHouseholds with hypertension and T2DM in cold regions of China face a high risk of CHE, particularly among those with lower economic status. There is a pressing need for a more equitable healthcare financing system and improved management of chronic diseases in these populations.

Indexed as

Catastrophic health expendituresChinaCold regionsHypertensionType 2 diabetes mellitus

Identifiers

PMID41085816
PMCPMC12522244

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.